找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Glaucoma Drainage Devices; A Practical Illustra Monica Gandhi,Shibal Bhartiya Book 2019 Springer Nature Singapore Pte Ltd. 2019 Surgical te

[復(fù)制鏈接]
樓主: OAK
31#
發(fā)表于 2025-3-26 23:41:19 | 只看該作者
32#
發(fā)表于 2025-3-27 04:10:28 | 只看該作者
33#
發(fā)表于 2025-3-27 08:15:49 | 只看該作者
34#
發(fā)表于 2025-3-27 11:10:05 | 只看該作者
https://doi.org/10.1007/978-3-662-48417-3tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
35#
發(fā)表于 2025-3-27 14:29:55 | 只看該作者
36#
發(fā)表于 2025-3-27 21:02:59 | 只看該作者
https://doi.org/10.1007/978-3-662-12009-5irreversible blindness. Therefore management of IOP may be required before, along with or after the patient has undergone PKP. Irreversible visual loss is seen due to optic nerve damage, and graft failure is caused by persistent rise in IOP leading to chronic corneal endothelial damage leading to corneal oedema and compromised graft clarity [1].
37#
發(fā)表于 2025-3-27 22:06:08 | 只看該作者
Ettore Majorana International Science Seriesprimary surgery of choice in refractory glaucomas like post-penetrating keratoplasty glaucoma, glaucoma following retinal surgery, neovascular glaucoma, and irido-corneal endothelial syndrome and in patients with scarred conjunctiva. They are frequently used in cases with failed trabeculectomy surgery also.
38#
發(fā)表于 2025-3-28 05:58:08 | 只看該作者
Preparing the Patient for the Glaucoma Drainage Device Surgery,tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
39#
發(fā)表于 2025-3-28 08:10:13 | 只看該作者
40#
發(fā)表于 2025-3-28 10:45:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 03:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
辽宁省| 岳阳市| 当阳市| 贵州省| 山西省| 海安县| 关岭| 灵璧县| 建水县| 淮安市| 元氏县| 陈巴尔虎旗| 响水县| 瑞安市| 齐河县| 漳平市| 嘉义市| 玛沁县| 甘孜县| 方城县| 高碑店市| 北海市| 青岛市| 青冈县| 佛坪县| 佛冈县| 张家港市| 如东县| 吴川市| 英吉沙县| 铜梁县| 密山市| 古浪县| 义乌市| 鹿邑县| 宜州市| 郴州市| 息烽县| 盐边县| 潜江市| 安仁县|